Enochian Biosciences, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK INC. | 08/11/2023 | 252,757 | $143,212 | -79.48% | 0.45% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2023 | 251,478 | $142,487 | 583.85% | 0.45% |
| VANGUARD GROUP INC | 08/14/2023 | 227,029 | $128,634 | -29.55% | 0.40% |
| HOULIHAN FINANCIAL RESOURCE GROUP, LTD. | 08/02/2023 | 201,500 | $193,000 | 100.00% | 0.36% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/11/2023 | 155,861 | $88,310 | -51.12% | 0.28% |
| GOLDMAN SACHS GROUP INC | 05/14/2024 | 118,105 | $66,918 | 753.85% | 0.21% |
| NATIXIS | 08/11/2023 | 100,000 | $56,660 | 67.44% | 0.18% |
| JANE STREET GROUP, LLC | 08/14/2023 | 83,128 | $47,100 | 100.00% | 0.15% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/11/2023 | 56,298 | $31,899 | 319.73% | 0.10% |
| STATE STREET CORP | 08/14/2023 | 52,087 | $29,512 | -83.06% | 0.09% |
| MORGAN STANLEY | 08/14/2023 | 46,361 | $26,268 | -38.70% | 0.08% |
| Y-INTERCEPT (HONG KONG) LTD | 08/14/2023 | 43,219 | $24,488 | 100.00% | 0.08% |
| TWO SIGMA ADVISERS, LP | 08/14/2023 | 33,200 | $18,811 | -41.13% | 0.06% |
| OLD MISSION CAPITAL LLC | 08/09/2023 | 32,262 | $18,279 | 100.00% | 0.06% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2023 | 31,023 | $17,578 | -44.75% | 0.06% |
| DEUTSCHE BANK AG\ | 08/14/2023 | 29,648 | $16,810 | -40.29% | 0.05% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 08/14/2023 | 29,235 | $16,565 | 100.00% | 0.05% |
| NORTHERN TRUST CORP | 08/11/2023 | 26,908 | $15,246 | -83.55% | 0.05% |
| BLAIR WILLIAM & CO/IL | 08/11/2023 | 26,000 | $14,732 | 0.00% | 0.05% |
| DIMENSIONAL FUND ADVISORS LP | 08/09/2023 | 12,734 | $7,215 | -0.06% | 0.02% |
| CITADEL ADVISORS LLC | 08/14/2023 | 11,900 | $6,743 | 100.00% | 0.02% |
| VIRTU FINANCIAL LLC | 07/27/2023 | 11,029 | $6,000 | 100.00% | 0.02% |
| BANK OF NEW YORK MELLON CORP | 08/03/2023 | 10,529 | $5,966 | -80.86% | 0.02% |
| JPMORGAN CHASE & CO | 08/11/2023 | 7,126 | $4,038 | -52.93% | 0.01% |
| RHUMBLINE ADVISERS | 08/08/2023 | 5,517 | $3,128 | -81.91% | 0.01% |
| BNP PARIBAS ARBITRAGE, SNC | 08/09/2023 | 3,395 | $1,924 | -66.49% | 0.01% |
| BANK OF AMERICA CORP /DE/ | 08/14/2023 | 1,781 | $1,008 | -93.86% | 0.00% |
| FMR LLC | 08/11/2023 | 828 | $469 | -80.29% | 0.00% |
| WELLS FARGO & COMPANY/MN | 08/15/2023 | 487 | $276 | -85.98% | 0.00% |
| CITIGROUP INC | 08/10/2023 | 3 | $2 | -99.60% | 0.00% |
| GROUP ONE TRADING, L.P. | 08/09/2023 | 1 | $1 | -98.55% | 0.00% |
| AMERICAN INTERNATIONAL GROUP, INC. | 08/04/2023 | 0 | $0 | -100.00% | 0.00% |
| BARCLAYS PLC | 09/20/2023 | 0 | $0 | -100.00% | 0.00% |
| LEGAL & GENERAL GROUP PLC | 08/14/2023 | 0 | $0 | -100.00% | 0.00% |
| NEW YORK STATE COMMON RETIREMENT FUND | 08/07/2023 | 0 | $0 | -100.00% | 0.00% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/10/2023 | 0 | $0 | -100.00% | 0.00% |
| INVESCO LTD. | 08/11/2023 | 0 | $0 | -100.00% | 0.00% |
| AMALGAMATED BANK | 08/11/2023 | 0 | $0 | -100.00% | 0.00% |
| ROYAL BANK OF CANADA | 08/14/2023 | 0 | $0 | -100.00% | 0.00% |
| AMERITAS INVESTMENT PARTNERS, INC. | 08/11/2023 | 0 | $0 | -100.00% | 0.00% |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 08/21/2023 | 0 | $0 | -100.00% | 0.00% |
| ALLIANCEBERNSTEIN L.P. | 08/15/2023 | 0 | $0 | -100.00% | 0.00% |
| HRT FINANCIAL LP | 08/11/2023 | 0 | $0 | -100.00% | 0.00% |
| NUVEEN ASSET MANAGEMENT, LLC | 08/16/2023 | 0 | $0 | -100.00% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 08/14/2023 | 0 | $0 | -100.00% | 0.00% |
| UBS GROUP AG | 08/11/2023 | 0 | $0 | -100.00% | 0.00% |
| ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC | 07/18/2023 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Enochian Biosciences, Inc. institutional Ownership - FAQ's
During the previous two years, 1 institutional investors and hedge funds held shares of Enochian Biosciences, Inc.. The most heavily invested institutionals were:
PARAMETRIC PORTFOLIO ASSOCIATES LLC: 16,872
3.29% of Enochian Biosciences, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 16,872 shares in the last 24 months. This purchase volume represents approximately $11,979 in transactions.